When to rebrand a biotech company that has outgrown its name

You walk into a partner meeting talking about a new therapeutic area. But your logo, your colors, your website, they all point to the old pipeline. The brand describes who you were. Not who you are now. And it costs you clarity in every conversation.

The science moved. The company changed. Maybe you added a platform. Maybe you shifted from research to clinical. Maybe a new CEO brought a new vision. The old brand was built for a different story. You feel it when your team stumbles through the elevator pitch. Or when a slide deck looks nothing like your website. That gap is your signal. Rebrand when the business has evolved faster than the brand. Not when someone is bored of the logo.

What it takes depends on how deep the disconnect runs. A refresh might mean tightening the story and updating the visual system. A full rebrand means starting with the position, then rebuilding the name, mark, voice, and every touchpoint. The more your offer has changed, the bigger the job. If you just raised a round or are heading into a new phase, expect more work. Not because it is expensive for the sake of it. Because the brand has to carry the business forward, not backward.

This week, do one thing. Gather your last three pitch decks. Your website. Your latest press release. Lay them side by side. If they do not tell the same story, stop. Do not commission a new logo. Do not redesign the website. Those are decorations. Start with the position. When the position is right, the identity follows. If you want a second set of eyes, I will look at what you have and tell you what I see. No pitch. Just clarity.

Once this is handled, your team tells the same story in every room. The website matches the deck. The deck matches the conversation. Investors, partners, and hires understand you faster. The brand does not just look right. It works right. And you stop explaining who you are. You just are.

Other questions about brand identity for Biotech and Life Sciences